Central Research Associates - Flourish - PPDS — Birmingham, Alabama

Central Research Associates - Flourish - PPDS is a clinical research site located in Birmingham, Alabama, United States 35205-1628.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Central Research Associates - Flourish - PPDS has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: RSV Immunisation, Type II Diabetes Mellitus, Adult Obesity.

Sponsors: Sanofi Pasteur, a Sanofi Company, Corxel Pharmaceuticals, Eccogene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central Research Associates - Flourish - PPDS?

Central Research Associates - Flourish - PPDS has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central Research Associates - Flourish - PPDS conducted?

Central Research Associates - Flourish - PPDS has 3 clinical trials on record, with 2 currently active. Their work covers RSV Immunisation, Type II Diabetes Mellitus, Adult Obesity.

Is Central Research Associates - Flourish - PPDS accredited by Crixeo Clinical Trials?

Central Research Associates - Flourish - PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Central Research Associates - Flourish - PPDS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.